Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204111
Max Phase: Preclinical
Molecular Formula: C24H24ClN3O5S
Molecular Weight: 501.99
Associated Items:
ID: ALA5204111
Max Phase: Preclinical
Molecular Formula: C24H24ClN3O5S
Molecular Weight: 501.99
Associated Items:
Canonical SMILES: COc1cc(OC)c(C2CC(c3ccc(Cl)cc3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1OC
Standard InChI: InChI=1S/C24H24ClN3O5S/c1-31-22-14-24(33-3)23(32-2)12-19(22)21-13-20(15-4-6-16(25)7-5-15)27-28(21)17-8-10-18(11-9-17)34(26,29)30/h4-12,14,21H,13H2,1-3H3,(H2,26,29,30)
Standard InChI Key: MYNLZQRULWJZIQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 501.99 | Molecular Weight (Monoisotopic): 501.1125 | AlogP: 4.37 | #Rotatable Bonds: 7 |
Polar Surface Area: 103.45 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.64 | CX Basic pKa: 3.57 | CX LogP: 4.15 | CX LogD: 4.15 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.52 | Np Likeness Score: -1.13 |
1. Kumar S, Rulhania S, Jaswal S, Monga V.. (2021) Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors., 209 [PMID:33121862] [10.1016/j.ejmech.2020.112923] |
Source(1):